NeuroSolve got the Tanzania Medicines and Medical Devices Authority (TMDA) regulatory trial approval

After obtaining the Ethical Clearance, NeuroSolve project finally got the Regulatory Approval too!

NeuroSolve Clinical Trial obtained the Regulatory Approval from Tanzania Medicines and Medical Devices Authority (TMDA).

This crucial step will allow us to officially start the NeuroSolve’s Clinical Trial on Neurocysticercosis in Tanzania, while Zambia will follow soon.

Leave a Reply

Your email address will not be published. Required fields are marked *